| AD | Alzheimer’s disease |
| ADRD | Alzheimer’s disease related dementias |
| APP | Amyloid precursor protein |
| Aβ | Amyloid-beta |
| BACE1 | β-site of APP cleaving enzyme 1 |
| CatD | Cathepsin D |
| CLIO | Cross-linked dextran iron oxide nanoparticles |
| CSF | Cerebrospinal fluid |
| CT | Computed tomography |
| DMEM | Dulbecco’s modified eagle medium |
| DMSO | Dimethyl sulfoxide |
| FBS | Fetal bovine serum |
| FTD | Frontotemporal disorders |
| HEK | Human embryonic kidney |
| HPLC | High-performance liquid chromatography |
| HRP | Horseradish peroxidase |
| Km | Michaelis constant |
| LBD | Lewy body dementia |
| MED | Mixed etiology dementia |
| MES | 2-(N-morpholino) ethanesulfonic acid |
| MI | Molecular imaging |
| MR | Magnetic resonance |
| MRI | Magnetic resonance imaging |
| NIRF | Near-infrared flourescence |
| PET | Positron emission tomography |
| SPECT | Single-photon emission computerized tomography |
| TBS-T | Tween 20 |
| VD | Vascular dementia |
| Vmax | Maximal velocity |